Ana
Alfonso Piérola
Investigadora Consultora
Massachusetts General Hospital
Boston, Estados UnidosPublications in collaboration with researchers from Massachusetts General Hospital (2)
2023
2021
-
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia, Vol. 35, Núm. 12, pp. 3542-3550